Lanean...
A Study of Thymidylate Synthase Expression as a Biomarker for Resectable Colon Cancer: Alliance (Cancer and Leukemia Group B) 9581 and 89803
PURPOSE. Tumor levels of thymidylate synthase (TS), a target of 5‐fluorouracil (5‐FU)‐based chemotherapy for colorectal cancer, have been studied as a predictive or prognostic biomarker with mixed results. PATIENTS AND METHODS. Tumor TS levels were prospectively evaluated in two adjuvant therapy tri...
Gorde:
Argitaratua izan da: | Oncologist |
---|---|
Egile Nagusiak: | , , , , , , , , , , , , , |
Formatua: | Artigo |
Hizkuntza: | Inglês |
Argitaratua: |
Wiley-Blackwell
2016
|
Gaiak: | |
Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5313270/ https://ncbi.nlm.nih.gov/pubmed/27821793 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0215 |
Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|